Since January 2014
Co-founder of Immunitrack a spin-out company from the University of Copenhagen. The company works in the field of important immunological molecules such as: the neonatal Fc receptor FcRn and major histocompability molecules (MHC).
February 2014 --- July 2015
Together with my collegue Stephan Thorgrimsen I have been granted a pre-seed grant by the Novonordic Foundation to provide proof of principle for the action of a novel FcRn blocking molecule I have developed. The project is a part of the Copenhagen Spin-Out initiative.
June 2008 --- December 2013
Worked on MHC I and II expression assays, tetramers FcRn, develoment of fusion tags for Half life enhancement. Development of FcRn blockers for treatment of autoimmune diseases. Development of a novel FcRn based affinity ligand for gentle purification of Fc fused molecules.
PH.D in Immunology from University of Copenhagen in 2008
M. Sc. Eng. in Biotechnology from Technical University of Denmark DTU in 2000